Clinical trials
Metabolic Syndrome trials in Russia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 3 |
| 2007 | 2 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Unknown status | 5 |
| Recruiting | 3 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| I.M. Sechenov First Moscow State Medical University | 2 |
| Abbott | 1 |
| Atlas Biomed | 1 |
| Bristol-Myers Squibb | 1 |
| Center of New Medical Technologies | 1 |
| Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 1 |
| Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health | 1 |
| GlaxoSmithKline | 1 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1 |
| National Medical Research Center for Therapy and Preventive Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Metabolic Syndrome | 15 |
| Dyslipidemias | 3 |
| Hypertension | 3 |
| Diabetes Mellitus, Type 2 | 2 |
| Hyperglycemia | 2 |
| Obesity | 2 |
| Body Weight | 1 |
| Diabetes Mellitus | 1 |
| Endocrine System Diseases | 1 |
| Hypertriglyceridemia | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.